Skip to main content
SpringerLink
Log in

Proven Efficacy of Combined Androgen Depletion Therapy

  • CLINICAL TRIAL REPORT
  • Published:
Current Urology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Akaza H, Yamaguchi A, Matsuda T, et al.: Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients. Jpn J Clin Oncol 2004, 34:20–28.

    Article  PubMed  Google Scholar 

  2. Usami M, Akaza H, Arai Y, et al.: Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients. Prostate Cancer Prostatic Dis 2007, 10:194–201.

    Article  CAS  PubMed  Google Scholar 

  3. Klotz L, Schellhammer P, Carroll K: A re-assessment of the role of combined androgen blockade for advanced prostate cancer. BJU Int 2004, 93:1177–1182.

    Article  CAS  PubMed  Google Scholar 

  4. Loblaw DA, Virgo KS, Nam R, et al.: Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol, 2007, 25:1596–1605.

    Article  CAS  PubMed  Google Scholar 

  5. Moul JW: Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer. Cancer 2009, 115:3376–3378.

    Article  PubMed  Google Scholar 

  6. Cooperberg MR, Hinotsu S, Namiki M, et al.: Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol 2009, 27:4306–4313.

    Article  PubMed  Google Scholar 

Download references

Disclosures

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Research Center for Advanced Science and Technology, The University of Tokyo, Komaba, Meguroku, Tokyo, 053-8904, Japan

    Hideyuki Akaza

Authors
  1. Hideyuki Akaza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideyuki Akaza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akaza, H. Proven Efficacy of Combined Androgen Depletion Therapy. Curr Urol Rep 11, 221–223 (2010). https://doi.org/10.1007/s11934-010-0117-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-010-0117-5

Keywords

Search

Navigation